Definitive Healthcare Corp. (DH)
NASDAQ: DH · Real-Time Price · USD
1.010
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
1.050
+0.040 (3.96%)
After-hours: Apr 28, 2026, 4:34 PM EDT
Definitive Healthcare Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Definitive Healthcare stock have an average target of 3.08, with a low estimate of 1.00 and a high estimate of 6.00. The average target predicts an increase of 204.95% from the current stock price of 1.01.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Definitive Healthcare stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Sell Maintains $2.75 → $1 | Sell | Maintains | $2.75 → $1 | -0.99% | Mar 30, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +197.03% | Feb 27, 2026 |
| Stephens & Co. | Stephens & Co. | Hold Maintains $3 → $2 | Hold | Maintains | $3 → $2 | +98.02% | Feb 27, 2026 |
| Barclays | Barclays | Sell Maintains $3 → $2.75 | Sell | Maintains | $3 → $2.75 | +172.28% | Dec 9, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +296.04% | Nov 10, 2025 |
Financial Forecast
Revenue This Year
230.35M
from 241.52M
Decreased by -4.63%
Revenue Next Year
232.05M
from 230.35M
Increased by 0.74%
EPS This Year
0.17
from -1.30
EPS Next Year
0.19
from 0.17
Increased by 11.51%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 237.0M | 246.1M | |
| Avg | 230.4M | 232.1M | |
| Low | 216.6M | 214.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.9% | 6.8% | |
| Avg | -4.6% | 0.7% | |
| Low | -10.3% | -6.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.20 | 0.23 | |
| Avg | 0.17 | 0.19 | |
| Low | 0.16 | 0.15 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 34.2% | |
| Avg | - | 11.5% | |
| Low | - | -14.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.